- Home
- BUD vs PFE Comparison
BUD vs PFE Comparison
Compare BUD & PFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUD
- PFE
- Stock Information
- Founded
- BUD 1366
- PFE 1849
- Country
- BUD Belgium
- PFE United States
- Employees
- BUD N/A
- PFE N/A
- Industry
- BUD Beverages (Production/Distribution)
- PFE Biotechnology: Pharmaceutical Preparations
- Sector
- BUD Consumer Staples
- PFE Health Care
- Exchange
- BUD Nasdaq
- PFE Nasdaq
- Market Cap
- BUD 121.4B
- PFE 139.3B
- IPO Year
- BUD N/A
- PFE N/A
- Fundamental
- Price
- BUD $62.10
- PFE $24.70
- Analyst Decision
- BUD Buy
- PFE Buy
- Analyst Count
- BUD 3
- PFE 13
- Target Price
- BUD $64.00
- PFE $31.92
- AVG Volume (30 Days)
- BUD 2.2M
- PFE 57.7M
- Earning Date
- BUD 05-07-2025
- PFE 04-29-2025
- Dividend Yield
- BUD 1.69%
- PFE 6.96%
- EPS Growth
- BUD 10.00
- PFE 284.33
- EPS
- BUD 2.86
- PFE 1.41
- Revenue
- BUD $59,768,000,000.00
- PFE $63,627,000,000.00
- Revenue This Year
- BUD $1.64
- PFE $0.10
- Revenue Next Year
- BUD $4.53
- PFE N/A
- P/E Ratio
- BUD $21.71
- PFE $17.49
- Revenue Growth
- BUD 0.65
- PFE 6.84
- 52 Week Low
- BUD $45.94
- PFE $24.31
- 52 Week High
- BUD $67.49
- PFE $31.54
- Technical
- Relative Strength Index (RSI)
- BUD 62.90
- PFE 36.08
- Support Level
- BUD $61.13
- PFE $25.50
- Resistance Level
- BUD $62.75
- PFE $25.43
- Average True Range (ATR)
- BUD 0.64
- PFE 0.48
- MACD
- BUD -0.49
- PFE -0.14
- Stochastic Oscillator
- BUD 39.27
- PFE 17.46
About BUD Anheuser-Busch Inbev SA Sponsored ADR (Belgium)
Anheuser-Busch InBev is the largest brewer in the world and one of the world's top five consumer product companies, as measured by EBITDA. The company's portfolio contains six of the top 10 beer brands by volume, according to Euromonitor, and we estimate it distributes 23 brands with retail sales over $1 billion. AB InBev was created by the 2008 merger of Belgium-based InBev and US-based Anheuser-Busch. The firm holds a 62% economic interest in Ambev, an 87% stake in Budweiser APAC, and in 2016 it acquired SABMiller.
About PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.